SCHEMBL21183245

SCHEMBL21183245

CC1CN(C(C)C(=O)N(C)C)C1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14754868 1.00 CHRNB2 (0.35) CHRNB2CHRNA4SMN1; SMN2
SCHEMBL14752138 0.82 PIK3CD (0.31)
SCHEMBL19156661 0.82 PIK3CD (0.31)
SCHEMBL19000154 0.76 SLC6A9 (0.40) CHRNB2CHRNA4SMN1; SMN2
SCHEMBL17010751 0.72 MAOB (0.41) CHRNB2CHRNA4SMN1; SMN2
SCHEMBL14754875 0.71 MEN1 (0.32) SMN1; SMN2
SCHEMBL19617146 0.71 MEN1 (0.37) SMN1; SMN2
SCHEMBL19135574 0.70 BCHE (0.35)
SCHEMBL15615636 0.69 MAPT (0.47) SMN1; SMN2
SCHEMBL12206867 0.69 PDK1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3513793-B1 HETEROCYCLYLAMINES AS PI3K INHIBITORS INCYTE HOLDINGS CORP (US) 2021-03-10 EP disclosed
EP-3513793-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS Incyte Holdings Corporation (US) 2019-07-24 EP disclosed